Amicus Therapeutics Inc (NASDAQ: FOLD): To Buy Or Not To Buy, That Is The Question
Amicus Therapeutics Inc (FOLD) concluded trading on Thursday at a closing price of $6.29, with 5.22 million shares of worth about $32.82 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -31.70% during that period and on July 17, 2025 the price saw a […]
An Important Check-Up On Amicus Therapeutics Inc (NASDAQ: FOLD)
Amicus Therapeutics Inc (FOLD) concluded trading on Wednesday at a closing price of $6.42, with 5.59 million shares of worth about $35.9 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -31.77% during that period and on July 09, 2025 the price saw a […]
Better Times Ahead For Amicus Therapeutics Inc (NASDAQ: FOLD)?
Amicus Therapeutics Inc (FOLD) concluded trading on Thursday at a closing price of $5.69, with 4.15 million shares of worth about $23.61 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -41.94% during that period and on June 26, 2025 the price saw a […]
Stick With Amicus Therapeutics Inc (FOLD). The Bull Are Alive And Well
Currently, there are 307.92M common shares owned by the public and among those 297.12M shares have been available to trade. The company’s stock has a 5-day price change of -5.07% and -35.41% over the past three months. FOLD shares are trading -38.43% year to date (YTD), with the 12-month market performance down to -45.51% lower. […]
Institutional Exposure To Amicus Therapeutics Inc (FOLD)
Amicus Therapeutics Inc (FOLD) concluded trading on Wednesday at a closing price of $6.14, with 4.8 million shares of worth about $29.47 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -36.90% during that period and on June 11, 2025 the price saw a […]
Growth Story Still Intact For Amicus Therapeutics Inc (FOLD)
Amicus Therapeutics Inc (FOLD) concluded trading on Wednesday at a closing price of $6.10, with 4.52 million shares of worth about $27.59 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -38.88% during that period and on June 04, 2025 the price saw a […]
Assessing Whether Amicus Therapeutics Inc (NASDAQ: FOLD) Is Over- Or Undervalued
Amicus Therapeutics Inc (FOLD) concluded trading on Wednesday at a closing price of $6.10, with 5.5 million shares of worth about $33.57 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -35.79% during that period and on Wednesday the price saw a loss of […]
Technical Outlook And Game Plan For Amicus Therapeutics Inc (NASDAQ: FOLD)
Amicus Therapeutics Inc (FOLD) concluded trading on Thursday at a closing price of $14.00, with 2.75 million shares of worth about $38.5 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 8.78% during that period and on Thursday the price saw a gain of […]
Uncovering Institutional Buying In Amicus Therapeutics Inc (NASDAQ: FOLD)
Currently, there are 293.25M common shares owned by the public and among those 284.30M shares have been available to trade. Insiders at the company have transacted a total of 71 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 28 of these insider trades were purchases, […]
Set Your Sights On Amicus Therapeutics Inc (NASDAQ: FOLD)’S Upside Potential
Perceptive Advisors LLC has recently announced that it has increased stake in Amicus Therapeutics Inc (NASDAQ:FOLD) by 0.11%. After grabbing 27.69 million shares, the institutional investor is now in possession of 30000.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 9.44% having worth around $305.18 million. Moreover, The […]